Summary
158.59 1.45(0.92%)05/21/2024
PNC Financial Services Group (PNC)
PNC Financial Services Group (PNC)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -0.17 | 1.93 | -3.04 | 5.36 | 29.28 | 33.47 | 31.97 | 20,854.42 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 156.15 | |
| Open | 157.04 | |
| High | 157.37 | |
| Low | 155.60 | |
| Volume | 805,061 | |
| Change | -0.27 | |
| Change % | -0.17 | |
| Avg Volume (20 Days) | 1,227,612 | |
| Volume/Avg Volume (20 Days) Ratio | 0.66 | |
| 52 Week Range | 109.40 - 162.22 | |
| Price vs 52 Week High | -3.74% | |
| Price vs 52 Week Low | 42.73% | |
| Range | -0.57 | |
| Gap Up/Down | -1.16 | |
Fundamentals | ||
| Market Capitalization (Mln) | 62,527 | |
| EBIDTA | 0 | |
| PE Ratio | 13.2309 | |
| PEG Ratio | 3.4582 | |
| WallStreet Target Price | 168.42 | |
| Book Value | 113.2960 | |
| Earnings Per Share | 11.9100 | |
| EPS Estimate Current Quarter | 3.0100 | |
| EPS Estimate Next Quarter | 2.9600 | |
| EPS Estimate Current Year | 12.6400 | |
| EPS Estimate Next Year | 14.3100 | |
| Diluted EPS (TTM) | 11.9100 | |
| Revenues | ||
| Profit Marging | 0.2568 | |
| Operating Marging (TTM) | 0.3319 | |
| Return on asset (TTM) | 0.0094 | |
| Return on equity (TTM) | 0.1055 | |
| Revenue TTM | 20,369,999,872 | |
| Revenue per share TTM | 50.8300 | |
| Quarterly Revenue Growth (YOY) | -0.0700 | |
| Quarterly Earnings Growth (YOY) | -0.2210 | |
| Gross Profit (TTM) | 20,643,000,000 | |
| Dividends | ||
| Dividend Share | 6.1500 | |
| Dividend Yield | 0.0393 | |
| Valuations | ||
| Trailing PE | 13.2309 | |
| Forward PE | 12.1065 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.1726 | |
| Revenue Enterprise Value | 0.0000 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 397,907,008 | |
| Shares Float | 394,612,509 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.01 | |
| Insider (%) | 0.37 | |
| Institutions (%) | 84.69 | |
05/20 05:08 EST - https://www.defenseworld.net
Private Advisor Group LLC Has $524,000 Stock Holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ)
Private Advisor Group LLC raised its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 24.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,791 shares of the company’s stock after purchasing an additional 6,935 shares during the period. Private Advisor Group LLC’s holdings in BlackRock Health Sciences Term Trust were worth $524,000 at the end of the most recent quarter. Other large investors also recently modified their holdings of the company. B. Riley Wealth Advisors Inc. raised its holdings in BlackRock Health Sciences Term Trust by 4.8% in the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 17,363 shares of the company’s stock valued at $250,000 after acquiring an additional 796 shares during the period. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 24.1% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 4,792 shares of the company’s stock worth $70,000 after buying an additional 930 shares in the last quarter. Janney Montgomery Scott LLC grew its stake in shares of BlackRock Health Sciences Term Trust by 4.0% in the third quarter. Janney Montgomery Scott LLC now owns 30,936 shares of the company’s stock valued at $446,000 after acquiring an additional 1,199 shares in the last quarter. LPL Financial LLC raised its stake in BlackRock Health Sciences Term Trust by 0.5% in the 3rd quarter. LPL Financial LLC now owns 274,665 shares of the company’s stock worth $3,958,000 after purchasing an additional 1,231 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its holdings in BlackRock Health Sciences Term Trust by 22.4% in the 3rd quarter. PNC Financial Services Group Inc. now owns 25,955 shares of the company’s stock valued at $374,000 after purchasing an additional 4,745 shares during the period. Insider Activity In other news, major shareholder Saba Capital Management, L.P. acquired 193,297 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were acquired at an average cost of 15.92 per share, with a total value of 3,077,288.24. Following the completion of the purchase, the insider now directly owns 19,578,308 shares of the company’s stock, valued at approximately 311,686,663.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last ninety days, insiders bought 701,207 shares of company stock worth $11,338,909. BlackRock Health Sciences Term Trust Trading Down 0.1 % NYSE BMEZ opened at 15.10 on Monday. The company has a 50 day moving average of 15.46 and a 200-day moving average of 15.10. BlackRock Health Sciences Term Trust has a 1-year low of 12.93 and a 1-year high of 16.59. BlackRock Health Sciences Term Trust Announces Dividend The company also recently announced a monthly dividend, which will be paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th will be issued a $0.09 dividend. This represents a $1.08 annualized dividend and a yield of 7.15%. The ex-dividend date is Tuesday, May 14th. BlackRock Health Sciences Term Trust Company Profile (Free Report) BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Private Advisor Group LLC Has $524,000 Stock Holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ)
Private Advisor Group LLC raised its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 24.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,791 shares of the company’s stock after purchasing an additional 6,935 shares during the period. Private Advisor Group LLC’s holdings in BlackRock Health Sciences Term Trust were worth $524,000 at the end of the most recent quarter. Other large investors also recently modified their holdings of the company. B. Riley Wealth Advisors Inc. raised its holdings in BlackRock Health Sciences Term Trust by 4.8% in the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 17,363 shares of the company’s stock valued at $250,000 after acquiring an additional 796 shares during the period. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 24.1% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 4,792 shares of the company’s stock worth $70,000 after buying an additional 930 shares in the last quarter. Janney Montgomery Scott LLC grew its stake in shares of BlackRock Health Sciences Term Trust by 4.0% in the third quarter. Janney Montgomery Scott LLC now owns 30,936 shares of the company’s stock valued at $446,000 after acquiring an additional 1,199 shares in the last quarter. LPL Financial LLC raised its stake in BlackRock Health Sciences Term Trust by 0.5% in the 3rd quarter. LPL Financial LLC now owns 274,665 shares of the company’s stock worth $3,958,000 after purchasing an additional 1,231 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its holdings in BlackRock Health Sciences Term Trust by 22.4% in the 3rd quarter. PNC Financial Services Group Inc. now owns 25,955 shares of the company’s stock valued at $374,000 after purchasing an additional 4,745 shares during the period. Insider Activity In other news, major shareholder Saba Capital Management, L.P. acquired 193,297 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were acquired at an average cost of 15.92 per share, with a total value of 3,077,288.24. Following the completion of the purchase, the insider now directly owns 19,578,308 shares of the company’s stock, valued at approximately 311,686,663.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last ninety days, insiders bought 701,207 shares of company stock worth $11,338,909. BlackRock Health Sciences Term Trust Trading Down 0.1 % NYSE BMEZ opened at 15.10 on Monday. The company has a 50 day moving average of 15.46 and a 200-day moving average of 15.10. BlackRock Health Sciences Term Trust has a 1-year low of 12.93 and a 1-year high of 16.59. BlackRock Health Sciences Term Trust Announces Dividend The company also recently announced a monthly dividend, which will be paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th will be issued a $0.09 dividend. This represents a $1.08 annualized dividend and a yield of 7.15%. The ex-dividend date is Tuesday, May 14th. BlackRock Health Sciences Term Trust Company Profile (Free Report) BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
05/20 05:04 EST - https://www.defenseworld.net
National Bank of Canada FI Has $53,000 Stake in Smith & Nephew plc (NYSE:SNN)
National Bank of Canada FI lifted its position in shares of Smith & Nephew plc (NYSE:SNN – Free Report) by 36.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,967 shares of the medical equipment provider’s stock after buying an additional 521 shares during the period. National Bank of Canada FI’s holdings in Smith & Nephew were worth $53,000 at the end of the most recent quarter. Other institutional investors and hedge funds also recently modified their holdings of the company. Scharf Investments LLC boosted its position in shares of Smith & Nephew by 20.5% during the fourth quarter. Scharf Investments LLC now owns 2,980,334 shares of the medical equipment provider’s stock worth $81,304,000 after buying an additional 506,474 shares during the period. PNC Financial Services Group Inc. grew its stake in Smith & Nephew by 17.4% in the third quarter. PNC Financial Services Group Inc. now owns 36,315 shares of the medical equipment provider’s stock valued at $900,000 after purchasing an additional 5,384 shares in the last quarter. Seed Wealth Management Inc. acquired a new position in shares of Smith & Nephew during the 4th quarter worth approximately $213,000. London & Capital Asset Management Ltd bought a new stake in shares of Smith & Nephew during the 4th quarter worth approximately $1,054,000. Finally, Kornitzer Capital Management Inc. KS raised its stake in shares of Smith & Nephew by 38.8% during the 4th quarter. Kornitzer Capital Management Inc. KS now owns 245,609 shares of the medical equipment provider’s stock worth $6,700,000 after purchasing an additional 68,609 shares in the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds. Smith & Nephew Stock Up 0.9 % Shares of NYSE:SNN opened at $26.09 on Monday. Smith & Nephew plc has a 52-week low of $21.52 and a 52-week high of $32.36. The company has a current ratio of 1.77, a quick ratio of 0.72 and a debt-to-equity ratio of 0.44. The company has a 50-day simple moving average of $25.21 and a 200 day simple moving average of $26.29. Smith & Nephew Dividend Announcement The firm also recently disclosed a semi-annual dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Tuesday, April 2nd will be given a $0.462 dividend. The ex-dividend date of this dividend is Monday, April 1st. This represents a dividend yield of 2.8%. Wall Street Analyst Weigh In Separately, StockNews.com downgraded shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Monday, May 13th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”. View Our Latest Stock Analysis on Smith & Nephew About Smith & Nephew (Free Report) Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. Read More Five stocks we like better than Smith & Nephew Canada Bond Market Holiday: How to Invest and Trade MarketBeat Week in Review – 5/13 – 5/17 What is a Special Dividend? Take-Two Interactive Software Offers 2nd Chance for Investors Are These Liquid Natural Gas Stocks Ready For An Upside Bounce? Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
National Bank of Canada FI Has $53,000 Stake in Smith & Nephew plc (NYSE:SNN)
National Bank of Canada FI lifted its position in shares of Smith & Nephew plc (NYSE:SNN – Free Report) by 36.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,967 shares of the medical equipment provider’s stock after buying an additional 521 shares during the period. National Bank of Canada FI’s holdings in Smith & Nephew were worth $53,000 at the end of the most recent quarter. Other institutional investors and hedge funds also recently modified their holdings of the company. Scharf Investments LLC boosted its position in shares of Smith & Nephew by 20.5% during the fourth quarter. Scharf Investments LLC now owns 2,980,334 shares of the medical equipment provider’s stock worth $81,304,000 after buying an additional 506,474 shares during the period. PNC Financial Services Group Inc. grew its stake in Smith & Nephew by 17.4% in the third quarter. PNC Financial Services Group Inc. now owns 36,315 shares of the medical equipment provider’s stock valued at $900,000 after purchasing an additional 5,384 shares in the last quarter. Seed Wealth Management Inc. acquired a new position in shares of Smith & Nephew during the 4th quarter worth approximately $213,000. London & Capital Asset Management Ltd bought a new stake in shares of Smith & Nephew during the 4th quarter worth approximately $1,054,000. Finally, Kornitzer Capital Management Inc. KS raised its stake in shares of Smith & Nephew by 38.8% during the 4th quarter. Kornitzer Capital Management Inc. KS now owns 245,609 shares of the medical equipment provider’s stock worth $6,700,000 after purchasing an additional 68,609 shares in the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds. Smith & Nephew Stock Up 0.9 % Shares of NYSE:SNN opened at $26.09 on Monday. Smith & Nephew plc has a 52-week low of $21.52 and a 52-week high of $32.36. The company has a current ratio of 1.77, a quick ratio of 0.72 and a debt-to-equity ratio of 0.44. The company has a 50-day simple moving average of $25.21 and a 200 day simple moving average of $26.29. Smith & Nephew Dividend Announcement The firm also recently disclosed a semi-annual dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Tuesday, April 2nd will be given a $0.462 dividend. The ex-dividend date of this dividend is Monday, April 1st. This represents a dividend yield of 2.8%. Wall Street Analyst Weigh In Separately, StockNews.com downgraded shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Monday, May 13th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”. View Our Latest Stock Analysis on Smith & Nephew About Smith & Nephew (Free Report) Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. Read More Five stocks we like better than Smith & Nephew Canada Bond Market Holiday: How to Invest and Trade MarketBeat Week in Review – 5/13 – 5/17 What is a Special Dividend? Take-Two Interactive Software Offers 2nd Chance for Investors Are These Liquid Natural Gas Stocks Ready For An Upside Bounce? Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
05/20 05:00 EST - https://www.defenseworld.net
Amalgamated Bank Sells 686 Shares of New Fortress Energy Inc. (NASDAQ:NFE)
Amalgamated Bank lowered its stake in shares of New Fortress Energy Inc. (NASDAQ:NFE – Free Report) by 5.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 13,130 shares of the company’s stock after selling 686 shares during the quarter. Amalgamated Bank’s holdings in New Fortress Energy were worth $495,000 at the end of the most recent quarter. Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Van ECK Associates Corp boosted its position in shares of New Fortress Energy by 15.3% during the third quarter. Van ECK Associates Corp now owns 3,623 shares of the company’s stock valued at $119,000 after buying an additional 482 shares during the period. ORG Partners LLC grew its position in New Fortress Energy by 14.3% in the 3rd quarter. ORG Partners LLC now owns 4,206 shares of the company’s stock valued at $138,000 after acquiring an additional 526 shares during the last quarter. Raymond James Financial Services Advisors Inc. purchased a new stake in New Fortress Energy in the fourth quarter worth $210,000. PNC Financial Services Group Inc. lifted its position in shares of New Fortress Energy by 5.0% during the third quarter. PNC Financial Services Group Inc. now owns 6,730 shares of the company’s stock worth $221,000 after purchasing an additional 319 shares during the last quarter. Finally, ELCO Management Co. LLC purchased a new position in New Fortress Energy in the 3rd quarter worth about $229,000. Hedge funds and other institutional investors own 58.61% of the company’s stock. Analysts Set New Price Targets Several research firms have issued reports on NFE. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of New Fortress Energy from $35.00 to $33.00 and set a “hold” rating for the company in a research report on Thursday, May 9th. Barclays dropped their price objective on New Fortress Energy from $32.00 to $27.00 and set an “equal weight” rating on the stock in a research note on Monday, May 6th. Finally, Stifel Nicolaus reduced their price objective on New Fortress Energy from $45.00 to $43.00 and set a “buy” rating on the stock in a report on Thursday, May 9th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $38.00. Read Our Latest Stock Analysis on New Fortress Energy New Fortress Energy Stock Up 2.5 % New Fortress Energy stock opened at $26.72 on Monday. New Fortress Energy Inc. has a twelve month low of $25.06 and a twelve month high of $40.04. The business has a fifty day moving average of $28.71 and a two-hundred day moving average of $32.62. The firm has a market cap of $5.48 billion, a P/E ratio of 12.15 and a beta of 1.55. The company has a quick ratio of 0.54, a current ratio of 0.66 and a debt-to-equity ratio of 3.74. New Fortress Energy (NASDAQ:NFE – Get Free Report) last posted its earnings results on Wednesday, May 8th. The company reported $0.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.60 by $0.07. New Fortress Energy had a return on equity of 31.34% and a net margin of 17.90%. The company had revenue of $690.30 million for the quarter, compared to analyst estimates of $602.41 million. During the same quarter in the previous year, the firm earned $0.90 earnings per share. The firm’s quarterly revenue was up 19.2% compared to the same quarter last year. On average, analysts forecast that New Fortress Energy Inc. will post 2.07 earnings per share for the current fiscal year. New Fortress Energy Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Thursday, June 27th. Shareholders of record on Saturday, June 15th will be issued a $0.10 dividend. This represents a $0.40 annualized dividend and a yield of 1.50%. The ex-dividend date of this dividend is Friday, June 14th. New Fortress Energy’s dividend payout ratio is currently 18.18%. New Fortress Energy Company Profile (Free Report) New Fortress Energy Inc operates as an integrated gas-to-power energy infrastructure company that provides energy and development services to end-users worldwide. The company operates in two segments, Terminals and Infrastructure, and Ships. The Terminals and Infrastructure segment engages in the natural gas procurement and liquefaction; and shipping, logistics, facilities and conversion, or development of natural gas-fired power generation. See Also Five stocks we like better than New Fortress Energy Retail Stocks Investing, Explained MarketBeat Week in Review – 5/13 – 5/17 Stock Ratings and Recommendations: Understanding Analyst Ratings Take-Two Interactive Software Offers 2nd Chance for Investors 3 Warren Buffett Stocks to Buy Now Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook Want to see what other hedge funds are holding NFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for New Fortress Energy Inc. (NASDAQ:NFE – Free Report).
Amalgamated Bank Sells 686 Shares of New Fortress Energy Inc. (NASDAQ:NFE)
Amalgamated Bank lowered its stake in shares of New Fortress Energy Inc. (NASDAQ:NFE – Free Report) by 5.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 13,130 shares of the company’s stock after selling 686 shares during the quarter. Amalgamated Bank’s holdings in New Fortress Energy were worth $495,000 at the end of the most recent quarter. Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Van ECK Associates Corp boosted its position in shares of New Fortress Energy by 15.3% during the third quarter. Van ECK Associates Corp now owns 3,623 shares of the company’s stock valued at $119,000 after buying an additional 482 shares during the period. ORG Partners LLC grew its position in New Fortress Energy by 14.3% in the 3rd quarter. ORG Partners LLC now owns 4,206 shares of the company’s stock valued at $138,000 after acquiring an additional 526 shares during the last quarter. Raymond James Financial Services Advisors Inc. purchased a new stake in New Fortress Energy in the fourth quarter worth $210,000. PNC Financial Services Group Inc. lifted its position in shares of New Fortress Energy by 5.0% during the third quarter. PNC Financial Services Group Inc. now owns 6,730 shares of the company’s stock worth $221,000 after purchasing an additional 319 shares during the last quarter. Finally, ELCO Management Co. LLC purchased a new position in New Fortress Energy in the 3rd quarter worth about $229,000. Hedge funds and other institutional investors own 58.61% of the company’s stock. Analysts Set New Price Targets Several research firms have issued reports on NFE. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of New Fortress Energy from $35.00 to $33.00 and set a “hold” rating for the company in a research report on Thursday, May 9th. Barclays dropped their price objective on New Fortress Energy from $32.00 to $27.00 and set an “equal weight” rating on the stock in a research note on Monday, May 6th. Finally, Stifel Nicolaus reduced their price objective on New Fortress Energy from $45.00 to $43.00 and set a “buy” rating on the stock in a report on Thursday, May 9th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $38.00. Read Our Latest Stock Analysis on New Fortress Energy New Fortress Energy Stock Up 2.5 % New Fortress Energy stock opened at $26.72 on Monday. New Fortress Energy Inc. has a twelve month low of $25.06 and a twelve month high of $40.04. The business has a fifty day moving average of $28.71 and a two-hundred day moving average of $32.62. The firm has a market cap of $5.48 billion, a P/E ratio of 12.15 and a beta of 1.55. The company has a quick ratio of 0.54, a current ratio of 0.66 and a debt-to-equity ratio of 3.74. New Fortress Energy (NASDAQ:NFE – Get Free Report) last posted its earnings results on Wednesday, May 8th. The company reported $0.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.60 by $0.07. New Fortress Energy had a return on equity of 31.34% and a net margin of 17.90%. The company had revenue of $690.30 million for the quarter, compared to analyst estimates of $602.41 million. During the same quarter in the previous year, the firm earned $0.90 earnings per share. The firm’s quarterly revenue was up 19.2% compared to the same quarter last year. On average, analysts forecast that New Fortress Energy Inc. will post 2.07 earnings per share for the current fiscal year. New Fortress Energy Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Thursday, June 27th. Shareholders of record on Saturday, June 15th will be issued a $0.10 dividend. This represents a $0.40 annualized dividend and a yield of 1.50%. The ex-dividend date of this dividend is Friday, June 14th. New Fortress Energy’s dividend payout ratio is currently 18.18%. New Fortress Energy Company Profile (Free Report) New Fortress Energy Inc operates as an integrated gas-to-power energy infrastructure company that provides energy and development services to end-users worldwide. The company operates in two segments, Terminals and Infrastructure, and Ships. The Terminals and Infrastructure segment engages in the natural gas procurement and liquefaction; and shipping, logistics, facilities and conversion, or development of natural gas-fired power generation. See Also Five stocks we like better than New Fortress Energy Retail Stocks Investing, Explained MarketBeat Week in Review – 5/13 – 5/17 Stock Ratings and Recommendations: Understanding Analyst Ratings Take-Two Interactive Software Offers 2nd Chance for Investors 3 Warren Buffett Stocks to Buy Now Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook Want to see what other hedge funds are holding NFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for New Fortress Energy Inc. (NASDAQ:NFE – Free Report).
05/20 04:58 EST - https://www.defenseworld.net
Natixis Advisors L.P. Invests $218,000 in Arbor Realty Trust, Inc. (NYSE:ABR)
Natixis Advisors L.P. purchased a new position in Arbor Realty Trust, Inc. (NYSE:ABR – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 14,368 shares of the real estate investment trust’s stock, valued at approximately $218,000. A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Sound Income Strategies LLC lifted its stake in Arbor Realty Trust by 322.1% in the 4th quarter. Sound Income Strategies LLC now owns 2,347 shares of the real estate investment trust’s stock worth $36,000 after purchasing an additional 1,791 shares in the last quarter. Anchor Investment Management LLC purchased a new position in Arbor Realty Trust during the fourth quarter worth approximately $41,000. Halpern Financial Inc. boosted its stake in Arbor Realty Trust by 601.8% during the fourth quarter. Halpern Financial Inc. now owns 3,509 shares of the real estate investment trust’s stock worth $52,000 after buying an additional 3,009 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in Arbor Realty Trust by 27.8% in the 3rd quarter. PNC Financial Services Group Inc. now owns 6,121 shares of the real estate investment trust’s stock valued at $93,000 after buying an additional 1,333 shares in the last quarter. Finally, Clearstead Advisors LLC acquired a new stake in shares of Arbor Realty Trust in the 3rd quarter worth $93,000. 57.25% of the stock is currently owned by institutional investors and hedge funds. Insider Buying and Selling In related news, Director William C. Green purchased 10,209 shares of Arbor Realty Trust stock in a transaction that occurred on Monday, March 18th. The stock was purchased at an average cost of $12.93 per share, with a total value of $132,002.37. Following the completion of the transaction, the director now directly owns 162,809 shares in the company, valued at $2,105,120.37. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 3.70% of the stock is owned by company insiders. Arbor Realty Trust Price Performance Shares of ABR opened at $13.89 on Monday. The firm has a market capitalization of $2.62 billion, a price-to-earnings ratio of 8.63 and a beta of 1.96. The firm’s fifty day simple moving average is $13.01 and its 200-day simple moving average is $13.45. Arbor Realty Trust, Inc. has a twelve month low of $11.77 and a twelve month high of $17.74. The company has a current ratio of 36.63, a quick ratio of 36.63 and a debt-to-equity ratio of 3.14. Arbor Realty Trust Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Friday, May 17th will be given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 12.38%. The ex-dividend date of this dividend is Thursday, May 16th. Arbor Realty Trust’s dividend payout ratio (DPR) is presently 106.83%. Analyst Upgrades and Downgrades ABR has been the topic of a number of analyst reports. TheStreet raised shares of Arbor Realty Trust from a “d+” rating to a “c” rating in a research note on Monday, March 18th. Keefe, Bruyette & Woods cut their target price on Arbor Realty Trust from $13.50 to $13.25 and set a “market perform” rating for the company in a research note on Wednesday, April 10th. JPMorgan Chase & Co. reduced their price objective on shares of Arbor Realty Trust from $12.50 to $12.00 and set an “underweight” rating on the stock in a report on Wednesday, April 10th. JMP Securities reduced their price target on shares of Arbor Realty Trust from $19.00 to $17.00 and set a “market outperform” rating on the stock in a research note on Thursday, February 1st. Finally, Wedbush restated a “neutral” rating and set a $13.00 price target on shares of Arbor Realty Trust in a research note on Monday, May 6th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $14.71. View Our Latest Research Report on ABR Arbor Realty Trust Company Profile (Free Report) Arbor Realty Trust, Inc invests in a diversified portfolio of structured finance assets in the multifamily, single-family rental, and commercial real estate markets in the United States. The company operates through Structured Business and Agency Business segments. It primarily invests in bridge and mezzanine loans, including junior participating interests in first mortgages, and preferred and direct equity, as well as real estate-related joint ventures, real estate-related notes, and various mortgage-related securities.
Natixis Advisors L.P. Invests $218,000 in Arbor Realty Trust, Inc. (NYSE:ABR)
Natixis Advisors L.P. purchased a new position in Arbor Realty Trust, Inc. (NYSE:ABR – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 14,368 shares of the real estate investment trust’s stock, valued at approximately $218,000. A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Sound Income Strategies LLC lifted its stake in Arbor Realty Trust by 322.1% in the 4th quarter. Sound Income Strategies LLC now owns 2,347 shares of the real estate investment trust’s stock worth $36,000 after purchasing an additional 1,791 shares in the last quarter. Anchor Investment Management LLC purchased a new position in Arbor Realty Trust during the fourth quarter worth approximately $41,000. Halpern Financial Inc. boosted its stake in Arbor Realty Trust by 601.8% during the fourth quarter. Halpern Financial Inc. now owns 3,509 shares of the real estate investment trust’s stock worth $52,000 after buying an additional 3,009 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in Arbor Realty Trust by 27.8% in the 3rd quarter. PNC Financial Services Group Inc. now owns 6,121 shares of the real estate investment trust’s stock valued at $93,000 after buying an additional 1,333 shares in the last quarter. Finally, Clearstead Advisors LLC acquired a new stake in shares of Arbor Realty Trust in the 3rd quarter worth $93,000. 57.25% of the stock is currently owned by institutional investors and hedge funds. Insider Buying and Selling In related news, Director William C. Green purchased 10,209 shares of Arbor Realty Trust stock in a transaction that occurred on Monday, March 18th. The stock was purchased at an average cost of $12.93 per share, with a total value of $132,002.37. Following the completion of the transaction, the director now directly owns 162,809 shares in the company, valued at $2,105,120.37. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 3.70% of the stock is owned by company insiders. Arbor Realty Trust Price Performance Shares of ABR opened at $13.89 on Monday. The firm has a market capitalization of $2.62 billion, a price-to-earnings ratio of 8.63 and a beta of 1.96. The firm’s fifty day simple moving average is $13.01 and its 200-day simple moving average is $13.45. Arbor Realty Trust, Inc. has a twelve month low of $11.77 and a twelve month high of $17.74. The company has a current ratio of 36.63, a quick ratio of 36.63 and a debt-to-equity ratio of 3.14. Arbor Realty Trust Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Friday, May 17th will be given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 12.38%. The ex-dividend date of this dividend is Thursday, May 16th. Arbor Realty Trust’s dividend payout ratio (DPR) is presently 106.83%. Analyst Upgrades and Downgrades ABR has been the topic of a number of analyst reports. TheStreet raised shares of Arbor Realty Trust from a “d+” rating to a “c” rating in a research note on Monday, March 18th. Keefe, Bruyette & Woods cut their target price on Arbor Realty Trust from $13.50 to $13.25 and set a “market perform” rating for the company in a research note on Wednesday, April 10th. JPMorgan Chase & Co. reduced their price objective on shares of Arbor Realty Trust from $12.50 to $12.00 and set an “underweight” rating on the stock in a report on Wednesday, April 10th. JMP Securities reduced their price target on shares of Arbor Realty Trust from $19.00 to $17.00 and set a “market outperform” rating on the stock in a research note on Thursday, February 1st. Finally, Wedbush restated a “neutral” rating and set a $13.00 price target on shares of Arbor Realty Trust in a research note on Monday, May 6th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $14.71. View Our Latest Research Report on ABR Arbor Realty Trust Company Profile (Free Report) Arbor Realty Trust, Inc invests in a diversified portfolio of structured finance assets in the multifamily, single-family rental, and commercial real estate markets in the United States. The company operates through Structured Business and Agency Business segments. It primarily invests in bridge and mezzanine loans, including junior participating interests in first mortgages, and preferred and direct equity, as well as real estate-related joint ventures, real estate-related notes, and various mortgage-related securities.
05/20 04:58 EST - https://www.defenseworld.net
Natixis Advisors L.P. Cuts Holdings in Core Laboratories Inc. (NYSE:CLB)
Natixis Advisors L.P. decreased its position in Core Laboratories Inc. (NYSE:CLB – Free Report) by 32.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,928 shares of the oil and gas company’s stock after selling 6,265 shares during the period. Natixis Advisors L.P.’s holdings in Core Laboratories were worth $228,000 at the end of the most recent quarter. Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC purchased a new position in Core Laboratories in the third quarter valued at $31,000. GAMMA Investing LLC purchased a new stake in shares of Core Laboratories during the fourth quarter worth about $48,000. PNC Financial Services Group Inc. increased its stake in shares of Core Laboratories by 72.7% during the third quarter. PNC Financial Services Group Inc. now owns 6,017 shares of the oil and gas company’s stock worth $144,000 after purchasing an additional 2,533 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Core Laboratories by 31.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,787 shares of the oil and gas company’s stock worth $259,000 after purchasing an additional 2,566 shares in the last quarter. Finally, Ballentine Partners LLC purchased a new stake in shares of Core Laboratories during the fourth quarter worth about $288,000. Hedge funds and other institutional investors own 97.81% of the company’s stock. Core Laboratories Stock Performance CLB opened at $18.04 on Monday. The firm has a market capitalization of $846.08 million, a PE ratio of 20.50, a PEG ratio of 1.02 and a beta of 2.40. Core Laboratories Inc. has a twelve month low of $13.82 and a twelve month high of $27.94. The firm’s 50-day moving average price is $16.89 and its 200 day moving average price is $16.88. The company has a current ratio of 2.68, a quick ratio of 1.85 and a debt-to-equity ratio of 0.68. Core Laboratories (NYSE:CLB – Get Free Report) last posted its earnings results on Wednesday, April 24th. The oil and gas company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.02. The company had revenue of $129.64 million for the quarter, compared to analyst estimates of $124.47 million. Core Laboratories had a net margin of 8.18% and a return on equity of 15.71%. As a group, sell-side analysts expect that Core Laboratories Inc. will post 0.8 EPS for the current fiscal year. Core Laboratories Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Shareholders of record on Monday, May 6th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Friday, May 3rd. This represents a $0.04 annualized dividend and a yield of 0.22%. Core Laboratories’s payout ratio is 4.55%. Wall Street Analysts Forecast Growth A number of analysts have recently commented on CLB shares. Stifel Nicolaus boosted their target price on shares of Core Laboratories from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, April 26th. Bank of America lowered their price target on shares of Core Laboratories from $17.00 to $16.00 and set an “underperform” rating on the stock in a research report on Monday, April 15th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $18.75. Check Out Our Latest Report on Core Laboratories About Core Laboratories (Free Report) Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Natixis Advisors L.P. Cuts Holdings in Core Laboratories Inc. (NYSE:CLB)
Natixis Advisors L.P. decreased its position in Core Laboratories Inc. (NYSE:CLB – Free Report) by 32.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,928 shares of the oil and gas company’s stock after selling 6,265 shares during the period. Natixis Advisors L.P.’s holdings in Core Laboratories were worth $228,000 at the end of the most recent quarter. Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC purchased a new position in Core Laboratories in the third quarter valued at $31,000. GAMMA Investing LLC purchased a new stake in shares of Core Laboratories during the fourth quarter worth about $48,000. PNC Financial Services Group Inc. increased its stake in shares of Core Laboratories by 72.7% during the third quarter. PNC Financial Services Group Inc. now owns 6,017 shares of the oil and gas company’s stock worth $144,000 after purchasing an additional 2,533 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Core Laboratories by 31.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,787 shares of the oil and gas company’s stock worth $259,000 after purchasing an additional 2,566 shares in the last quarter. Finally, Ballentine Partners LLC purchased a new stake in shares of Core Laboratories during the fourth quarter worth about $288,000. Hedge funds and other institutional investors own 97.81% of the company’s stock. Core Laboratories Stock Performance CLB opened at $18.04 on Monday. The firm has a market capitalization of $846.08 million, a PE ratio of 20.50, a PEG ratio of 1.02 and a beta of 2.40. Core Laboratories Inc. has a twelve month low of $13.82 and a twelve month high of $27.94. The firm’s 50-day moving average price is $16.89 and its 200 day moving average price is $16.88. The company has a current ratio of 2.68, a quick ratio of 1.85 and a debt-to-equity ratio of 0.68. Core Laboratories (NYSE:CLB – Get Free Report) last posted its earnings results on Wednesday, April 24th. The oil and gas company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.02. The company had revenue of $129.64 million for the quarter, compared to analyst estimates of $124.47 million. Core Laboratories had a net margin of 8.18% and a return on equity of 15.71%. As a group, sell-side analysts expect that Core Laboratories Inc. will post 0.8 EPS for the current fiscal year. Core Laboratories Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Shareholders of record on Monday, May 6th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Friday, May 3rd. This represents a $0.04 annualized dividend and a yield of 0.22%. Core Laboratories’s payout ratio is 4.55%. Wall Street Analysts Forecast Growth A number of analysts have recently commented on CLB shares. Stifel Nicolaus boosted their target price on shares of Core Laboratories from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, April 26th. Bank of America lowered their price target on shares of Core Laboratories from $17.00 to $16.00 and set an “underperform” rating on the stock in a research report on Monday, April 15th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $18.75. Check Out Our Latest Report on Core Laboratories About Core Laboratories (Free Report) Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
05/20 04:54 EST - https://www.defenseworld.net
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Swiss National Bank
Swiss National Bank reduced its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 9.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 128,200 shares of the medical device company’s stock after selling 13,800 shares during the quarter. Swiss National Bank owned about 0.20% of Tandem Diabetes Care worth $3,792,000 at the end of the most recent reporting period. A number of other hedge funds have also modified their holdings of the business. RiverPark Advisors LLC acquired a new stake in Tandem Diabetes Care during the 4th quarter worth $27,000. Signaturefd LLC raised its stake in Tandem Diabetes Care by 871.8% during the 4th quarter. Signaturefd LLC now owns 1,691 shares of the medical device company’s stock valued at $50,000 after acquiring an additional 1,517 shares during the last quarter. GAMMA Investing LLC acquired a new stake in Tandem Diabetes Care during the 4th quarter worth approximately $73,000. PNC Financial Services Group Inc. grew its stake in shares of Tandem Diabetes Care by 51.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 3,226 shares of the medical device company’s stock valued at $67,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Creative Financial Designs Inc. ADV acquired a new position in shares of Tandem Diabetes Care in the fourth quarter valued at approximately $104,000. Analyst Upgrades and Downgrades A number of research firms recently weighed in on TNDM. Piper Sandler restated an “overweight” rating and issued a $50.00 price target (up from $35.00) on shares of Tandem Diabetes Care in a research note on Friday, May 3rd. Leerink Partnrs upgraded shares of Tandem Diabetes Care from a “market perform” rating to an “outperform” rating in a research report on Thursday, April 25th. SVB Leerink upgraded shares of Tandem Diabetes Care from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $34.00 to $45.00 in a research report on Thursday, April 25th. Citigroup upped their price target on Tandem Diabetes Care from $31.00 to $38.00 and gave the stock a “neutral” rating in a report on Wednesday, April 3rd. Finally, Stifel Nicolaus lifted their price objective on Tandem Diabetes Care from $37.00 to $40.00 and gave the stock a “buy” rating in a report on Tuesday, April 23rd. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, Tandem Diabetes Care presently has a consensus rating of “Moderate Buy” and an average target price of $43.80. Check Out Our Latest Analysis on Tandem Diabetes Care Tandem Diabetes Care Stock Performance NASDAQ TNDM opened at $47.30 on Monday. Tandem Diabetes Care, Inc. has a twelve month low of $13.82 and a twelve month high of $47.88. The business’s 50-day moving average price is $35.59 and its 200 day moving average price is $28.04. The company has a current ratio of 3.81, a quick ratio of 3.01 and a debt-to-equity ratio of 1.43. The company has a market capitalization of $3.06 billion, a PE ratio of -21.80 and a beta of 1.10. Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) last issued its quarterly earnings results on Wednesday, February 21st. The medical device company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.04). The company had revenue of $196.80 million for the quarter, compared to analyst estimates of $204.86 million. Tandem Diabetes Care had a negative return on equity of 34.38% and a negative net margin of 18.37%. On average, research analysts predict that Tandem Diabetes Care, Inc. will post -1.7 earnings per share for the current year. Tandem Diabetes Care Profile (Free Report) Tandem Diabetes Care, Inc, a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Swiss National Bank
Swiss National Bank reduced its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 9.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 128,200 shares of the medical device company’s stock after selling 13,800 shares during the quarter. Swiss National Bank owned about 0.20% of Tandem Diabetes Care worth $3,792,000 at the end of the most recent reporting period. A number of other hedge funds have also modified their holdings of the business. RiverPark Advisors LLC acquired a new stake in Tandem Diabetes Care during the 4th quarter worth $27,000. Signaturefd LLC raised its stake in Tandem Diabetes Care by 871.8% during the 4th quarter. Signaturefd LLC now owns 1,691 shares of the medical device company’s stock valued at $50,000 after acquiring an additional 1,517 shares during the last quarter. GAMMA Investing LLC acquired a new stake in Tandem Diabetes Care during the 4th quarter worth approximately $73,000. PNC Financial Services Group Inc. grew its stake in shares of Tandem Diabetes Care by 51.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 3,226 shares of the medical device company’s stock valued at $67,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Creative Financial Designs Inc. ADV acquired a new position in shares of Tandem Diabetes Care in the fourth quarter valued at approximately $104,000. Analyst Upgrades and Downgrades A number of research firms recently weighed in on TNDM. Piper Sandler restated an “overweight” rating and issued a $50.00 price target (up from $35.00) on shares of Tandem Diabetes Care in a research note on Friday, May 3rd. Leerink Partnrs upgraded shares of Tandem Diabetes Care from a “market perform” rating to an “outperform” rating in a research report on Thursday, April 25th. SVB Leerink upgraded shares of Tandem Diabetes Care from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $34.00 to $45.00 in a research report on Thursday, April 25th. Citigroup upped their price target on Tandem Diabetes Care from $31.00 to $38.00 and gave the stock a “neutral” rating in a report on Wednesday, April 3rd. Finally, Stifel Nicolaus lifted their price objective on Tandem Diabetes Care from $37.00 to $40.00 and gave the stock a “buy” rating in a report on Tuesday, April 23rd. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, Tandem Diabetes Care presently has a consensus rating of “Moderate Buy” and an average target price of $43.80. Check Out Our Latest Analysis on Tandem Diabetes Care Tandem Diabetes Care Stock Performance NASDAQ TNDM opened at $47.30 on Monday. Tandem Diabetes Care, Inc. has a twelve month low of $13.82 and a twelve month high of $47.88. The business’s 50-day moving average price is $35.59 and its 200 day moving average price is $28.04. The company has a current ratio of 3.81, a quick ratio of 3.01 and a debt-to-equity ratio of 1.43. The company has a market capitalization of $3.06 billion, a PE ratio of -21.80 and a beta of 1.10. Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) last issued its quarterly earnings results on Wednesday, February 21st. The medical device company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.04). The company had revenue of $196.80 million for the quarter, compared to analyst estimates of $204.86 million. Tandem Diabetes Care had a negative return on equity of 34.38% and a negative net margin of 18.37%. On average, research analysts predict that Tandem Diabetes Care, Inc. will post -1.7 earnings per share for the current year. Tandem Diabetes Care Profile (Free Report) Tandem Diabetes Care, Inc, a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system.
05/20 04:42 EST - https://www.defenseworld.net
Swiss National Bank Sells 9,000 Shares of Envestnet, Inc. (NYSE:ENV)
Swiss National Bank lessened its holdings in shares of Envestnet, Inc. (NYSE:ENV – Free Report) by 10.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 80,700 shares of the business services provider’s stock after selling 9,000 shares during the quarter. Swiss National Bank owned about 0.15% of Envestnet worth $3,996,000 at the end of the most recent quarter. Other large investors also recently added to or reduced their stakes in the company. Headlands Technologies LLC purchased a new stake in Envestnet during the 3rd quarter valued at approximately $45,000. PNC Financial Services Group Inc. increased its holdings in Envestnet by 19.4% in the 3rd quarter. PNC Financial Services Group Inc. now owns 4,930 shares of the business services provider’s stock valued at $217,000 after acquiring an additional 802 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in Envestnet by 75.3% in the 3rd quarter. Tower Research Capital LLC TRC now owns 6,788 shares of the business services provider’s stock worth $299,000 after purchasing an additional 2,915 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Envestnet during the 3rd quarter valued at about $420,000. Finally, Truist Financial Corp purchased a new position in shares of Envestnet during the fourth quarter valued at about $433,000. Insider Buying and Selling at Envestnet In other news, insider Matthew Majoros sold 700 shares of the stock in a transaction that occurred on Monday, March 25th. The shares were sold at an average price of $56.92, for a total transaction of $39,844.00. Following the transaction, the insider now directly owns 15,212 shares in the company, valued at $865,867.04. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Lauren Taylor Wolfe acquired 1,670 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The shares were bought at an average price of $52.99 per share, with a total value of $88,493.30. Following the completion of the transaction, the director now directly owns 4,188,871 shares in the company, valued at $221,968,274.29. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Matthew Majoros sold 700 shares of the stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $56.92, for a total transaction of $39,844.00. Following the sale, the insider now directly owns 15,212 shares of the company’s stock, valued at $865,867.04. The disclosure for this sale can be found here. Insiders own 8.90% of the company’s stock. Envestnet Price Performance ENV opened at $67.81 on Monday. The business has a fifty day moving average of $60.10 and a 200 day moving average of $51.46. The stock has a market cap of $3.74 billion, a P/E ratio of -19.05 and a beta of 1.26. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 1.47. Envestnet, Inc. has a 52-week low of $33.12 and a 52-week high of $68.83. Envestnet (NYSE:ENV – Get Free Report) last announced its quarterly earnings data on Thursday, February 22nd. The business services provider reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.33 by $0.10. The company had revenue of $317.63 million during the quarter, compared to analyst estimates of $312.24 million. Envestnet had a negative net margin of 15.33% and a positive return on equity of 14.75%. As a group, sell-side analysts anticipate that Envestnet, Inc. will post 1.78 EPS for the current year. Wall Street Analyst Weigh In ENV has been the subject of a number of research reports. Jefferies Financial Group raised Envestnet from an “underperform” rating to a “hold” rating and increased their price target for the company from $47.00 to $59.00 in a research note on Wednesday, May 8th. DA Davidson lifted their price objective on shares of Envestnet from $62.00 to $67.00 and gave the stock a “buy” rating in a research note on Tuesday, April 2nd. JPMorgan Chase & Co. upped their target price on shares of Envestnet from $44.00 to $45.00 and gave the company a “neutral” rating in a research report on Friday, February 23rd. Raymond James lifted their price target on Envestnet from $52.00 to $60.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 2nd. Finally, Royal Bank of Canada boosted their target price on Envestnet from $56.00 to $64.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 8th. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $64.14. Check Out Our Latest Analysis on Envestnet Envestnet Company Profile (Free Report) Envestnet, Inc, through its subsidiaries, provides wealth management software and services in the United States and internationally. It operates through two segments: Envestnet Wealth Solutions and Envestnet Data & Analytics. The Envestnet Wealth Solutions segment offers Envestnet | Enterprise, an end-to-end open architecture wealth management platform, as well as offers data aggregation and reporting, data analytics, and digital advice capabilities; Envestnet | Wealth Analytics that transforms data into actionable intelligence; Envestnet | Tamarac which provides trading, rebalancing, portfolio accounting, performance reporting, and client relationship management software; and Envestnet | MoneyGuide that provides goals-based financial planning solutions to the financial services industry.
Swiss National Bank Sells 9,000 Shares of Envestnet, Inc. (NYSE:ENV)
Swiss National Bank lessened its holdings in shares of Envestnet, Inc. (NYSE:ENV – Free Report) by 10.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 80,700 shares of the business services provider’s stock after selling 9,000 shares during the quarter. Swiss National Bank owned about 0.15% of Envestnet worth $3,996,000 at the end of the most recent quarter. Other large investors also recently added to or reduced their stakes in the company. Headlands Technologies LLC purchased a new stake in Envestnet during the 3rd quarter valued at approximately $45,000. PNC Financial Services Group Inc. increased its holdings in Envestnet by 19.4% in the 3rd quarter. PNC Financial Services Group Inc. now owns 4,930 shares of the business services provider’s stock valued at $217,000 after acquiring an additional 802 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in Envestnet by 75.3% in the 3rd quarter. Tower Research Capital LLC TRC now owns 6,788 shares of the business services provider’s stock worth $299,000 after purchasing an additional 2,915 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Envestnet during the 3rd quarter valued at about $420,000. Finally, Truist Financial Corp purchased a new position in shares of Envestnet during the fourth quarter valued at about $433,000. Insider Buying and Selling at Envestnet In other news, insider Matthew Majoros sold 700 shares of the stock in a transaction that occurred on Monday, March 25th. The shares were sold at an average price of $56.92, for a total transaction of $39,844.00. Following the transaction, the insider now directly owns 15,212 shares in the company, valued at $865,867.04. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Lauren Taylor Wolfe acquired 1,670 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The shares were bought at an average price of $52.99 per share, with a total value of $88,493.30. Following the completion of the transaction, the director now directly owns 4,188,871 shares in the company, valued at $221,968,274.29. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Matthew Majoros sold 700 shares of the stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $56.92, for a total transaction of $39,844.00. Following the sale, the insider now directly owns 15,212 shares of the company’s stock, valued at $865,867.04. The disclosure for this sale can be found here. Insiders own 8.90% of the company’s stock. Envestnet Price Performance ENV opened at $67.81 on Monday. The business has a fifty day moving average of $60.10 and a 200 day moving average of $51.46. The stock has a market cap of $3.74 billion, a P/E ratio of -19.05 and a beta of 1.26. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 1.47. Envestnet, Inc. has a 52-week low of $33.12 and a 52-week high of $68.83. Envestnet (NYSE:ENV – Get Free Report) last announced its quarterly earnings data on Thursday, February 22nd. The business services provider reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.33 by $0.10. The company had revenue of $317.63 million during the quarter, compared to analyst estimates of $312.24 million. Envestnet had a negative net margin of 15.33% and a positive return on equity of 14.75%. As a group, sell-side analysts anticipate that Envestnet, Inc. will post 1.78 EPS for the current year. Wall Street Analyst Weigh In ENV has been the subject of a number of research reports. Jefferies Financial Group raised Envestnet from an “underperform” rating to a “hold” rating and increased their price target for the company from $47.00 to $59.00 in a research note on Wednesday, May 8th. DA Davidson lifted their price objective on shares of Envestnet from $62.00 to $67.00 and gave the stock a “buy” rating in a research note on Tuesday, April 2nd. JPMorgan Chase & Co. upped their target price on shares of Envestnet from $44.00 to $45.00 and gave the company a “neutral” rating in a research report on Friday, February 23rd. Raymond James lifted their price target on Envestnet from $52.00 to $60.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 2nd. Finally, Royal Bank of Canada boosted their target price on Envestnet from $56.00 to $64.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 8th. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $64.14. Check Out Our Latest Analysis on Envestnet Envestnet Company Profile (Free Report) Envestnet, Inc, through its subsidiaries, provides wealth management software and services in the United States and internationally. It operates through two segments: Envestnet Wealth Solutions and Envestnet Data & Analytics. The Envestnet Wealth Solutions segment offers Envestnet | Enterprise, an end-to-end open architecture wealth management platform, as well as offers data aggregation and reporting, data analytics, and digital advice capabilities; Envestnet | Wealth Analytics that transforms data into actionable intelligence; Envestnet | Tamarac which provides trading, rebalancing, portfolio accounting, performance reporting, and client relationship management software; and Envestnet | MoneyGuide that provides goals-based financial planning solutions to the financial services industry.
05/20 04:42 EST - https://www.defenseworld.net
Camtek Ltd. (NASDAQ:CAMT) Stake Lowered by Swiss National Bank
Swiss National Bank cut its stake in Camtek Ltd. (NASDAQ:CAMT – Free Report) by 10.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 57,537 shares of the semiconductor company’s stock after selling 6,593 shares during the quarter. Swiss National Bank owned approximately 0.13% of Camtek worth $4,053,000 as of its most recent filing with the Securities and Exchange Commission. Other institutional investors have also recently bought and sold shares of the company. Optimum Investment Advisors lifted its holdings in shares of Camtek by 15.0% during the 4th quarter. Optimum Investment Advisors now owns 1,725 shares of the semiconductor company’s stock valued at $120,000 after buying an additional 225 shares during the last quarter. PNC Financial Services Group Inc. grew its position in Camtek by 431.5% in the third quarter. PNC Financial Services Group Inc. now owns 1,940 shares of the semiconductor company’s stock worth $121,000 after acquiring an additional 1,575 shares in the last quarter. C M Bidwell & Associates Ltd. increased its stake in shares of Camtek by 3,062.2% during the 3rd quarter. C M Bidwell & Associates Ltd. now owns 2,846 shares of the semiconductor company’s stock worth $177,000 after purchasing an additional 2,756 shares during the last quarter. WINTON GROUP Ltd bought a new position in shares of Camtek during the 3rd quarter valued at $207,000. Finally, Commonwealth Equity Services LLC acquired a new stake in shares of Camtek in the 3rd quarter valued at $267,000. Institutional investors and hedge funds own 41.93% of the company’s stock. Camtek Price Performance Shares of NASDAQ:CAMT opened at $97.10 on Monday. The firm has a market capitalization of $4.36 billion, a PE ratio of 54.86, a PEG ratio of 3.22 and a beta of 1.39. The company has a current ratio of 3.66, a quick ratio of 3.08 and a debt-to-equity ratio of 0.44. Camtek Ltd. has a 1-year low of $27.14 and a 1-year high of $100.95. The business’s 50 day moving average is $82.62 and its 200-day moving average is $75.25. Camtek (NASDAQ:CAMT – Get Free Report) last posted its quarterly earnings results on Tuesday, February 20th. The semiconductor company reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.53 by $0.04. The firm had revenue of $88.70 million for the quarter, compared to the consensus estimate of $88.02 million. Camtek had a net margin of 25.35% and a return on equity of 20.94%. The business’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.45 earnings per share. Sell-side analysts predict that Camtek Ltd. will post 2.19 earnings per share for the current year. Camtek Announces Dividend The business also recently disclosed a Variable dividend, which was paid on Thursday, April 18th. Shareholders of record on Thursday, April 4th were issued a dividend of $1.33 per share. The ex-dividend date was Wednesday, April 3rd. Camtek’s payout ratio is 75.14%. Analyst Upgrades and Downgrades Several equities analysts have weighed in on the company. Needham & Company LLC raised their target price on Camtek from $92.00 to $106.00 and gave the company a “buy” rating in a report on Friday, May 10th. Northland Capmk lowered Camtek from a “strong-buy” rating to a “hold” rating in a report on Thursday. Jefferies Financial Group began coverage on Camtek in a report on Monday, May 13th. They set a “buy” rating and a $120.00 price target on the stock. B. Riley reaffirmed a “buy” rating and set a $110.00 price objective (up from $102.00) on shares of Camtek in a report on Friday, May 10th. Finally, Northland Securities lowered Camtek from an “outperform” rating to a “market perform” rating in a research note on Thursday. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $90.50. Read Our Latest Stock Report on CAMT Camtek Profile (Free Report) Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry. The company provides Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to address the challenges fanout wafer level packaging applications. See Also Five stocks we like better than Camtek 3 Stocks to Consider Buying in October MarketBeat Week in Review – 5/13 – 5/17 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion Take-Two Interactive Software Offers 2nd Chance for Investors Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours? Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
Camtek Ltd. (NASDAQ:CAMT) Stake Lowered by Swiss National Bank
Swiss National Bank cut its stake in Camtek Ltd. (NASDAQ:CAMT – Free Report) by 10.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 57,537 shares of the semiconductor company’s stock after selling 6,593 shares during the quarter. Swiss National Bank owned approximately 0.13% of Camtek worth $4,053,000 as of its most recent filing with the Securities and Exchange Commission. Other institutional investors have also recently bought and sold shares of the company. Optimum Investment Advisors lifted its holdings in shares of Camtek by 15.0% during the 4th quarter. Optimum Investment Advisors now owns 1,725 shares of the semiconductor company’s stock valued at $120,000 after buying an additional 225 shares during the last quarter. PNC Financial Services Group Inc. grew its position in Camtek by 431.5% in the third quarter. PNC Financial Services Group Inc. now owns 1,940 shares of the semiconductor company’s stock worth $121,000 after acquiring an additional 1,575 shares in the last quarter. C M Bidwell & Associates Ltd. increased its stake in shares of Camtek by 3,062.2% during the 3rd quarter. C M Bidwell & Associates Ltd. now owns 2,846 shares of the semiconductor company’s stock worth $177,000 after purchasing an additional 2,756 shares during the last quarter. WINTON GROUP Ltd bought a new position in shares of Camtek during the 3rd quarter valued at $207,000. Finally, Commonwealth Equity Services LLC acquired a new stake in shares of Camtek in the 3rd quarter valued at $267,000. Institutional investors and hedge funds own 41.93% of the company’s stock. Camtek Price Performance Shares of NASDAQ:CAMT opened at $97.10 on Monday. The firm has a market capitalization of $4.36 billion, a PE ratio of 54.86, a PEG ratio of 3.22 and a beta of 1.39. The company has a current ratio of 3.66, a quick ratio of 3.08 and a debt-to-equity ratio of 0.44. Camtek Ltd. has a 1-year low of $27.14 and a 1-year high of $100.95. The business’s 50 day moving average is $82.62 and its 200-day moving average is $75.25. Camtek (NASDAQ:CAMT – Get Free Report) last posted its quarterly earnings results on Tuesday, February 20th. The semiconductor company reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.53 by $0.04. The firm had revenue of $88.70 million for the quarter, compared to the consensus estimate of $88.02 million. Camtek had a net margin of 25.35% and a return on equity of 20.94%. The business’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.45 earnings per share. Sell-side analysts predict that Camtek Ltd. will post 2.19 earnings per share for the current year. Camtek Announces Dividend The business also recently disclosed a Variable dividend, which was paid on Thursday, April 18th. Shareholders of record on Thursday, April 4th were issued a dividend of $1.33 per share. The ex-dividend date was Wednesday, April 3rd. Camtek’s payout ratio is 75.14%. Analyst Upgrades and Downgrades Several equities analysts have weighed in on the company. Needham & Company LLC raised their target price on Camtek from $92.00 to $106.00 and gave the company a “buy” rating in a report on Friday, May 10th. Northland Capmk lowered Camtek from a “strong-buy” rating to a “hold” rating in a report on Thursday. Jefferies Financial Group began coverage on Camtek in a report on Monday, May 13th. They set a “buy” rating and a $120.00 price target on the stock. B. Riley reaffirmed a “buy” rating and set a $110.00 price objective (up from $102.00) on shares of Camtek in a report on Friday, May 10th. Finally, Northland Securities lowered Camtek from an “outperform” rating to a “market perform” rating in a research note on Thursday. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $90.50. Read Our Latest Stock Report on CAMT Camtek Profile (Free Report) Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry. The company provides Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to address the challenges fanout wafer level packaging applications. See Also Five stocks we like better than Camtek 3 Stocks to Consider Buying in October MarketBeat Week in Review – 5/13 – 5/17 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion Take-Two Interactive Software Offers 2nd Chance for Investors Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours? Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
05/20 01:06 EST - https://www.defenseworld.net
Q2 2024 EPS Estimates for PSQ Holdings, Inc. Reduced by Roth Capital (NYSE:PSQH)
PSQ Holdings, Inc. (NYSE:PSQH – Free Report) – Equities researchers at Roth Capital cut their Q2 2024 EPS estimates for shares of PSQ in a report released on Thursday, May 16th. Roth Capital analyst D. Aftahi now forecasts that the company will post earnings per share of ($0.30) for the quarter, down from their previous estimate of ($0.26). Roth Capital also issued estimates for PSQ’s Q3 2024 earnings at ($0.28) EPS, Q4 2024 earnings at ($0.24) EPS, Q1 2025 earnings at ($0.24) EPS, Q2 2025 earnings at ($0.22) EPS, Q3 2025 earnings at ($0.20) EPS, Q4 2025 earnings at ($0.17) EPS and FY2025 earnings at ($0.83) EPS. Separately, Roth Mkm reissued a “buy” rating and issued a $7.50 price target (down previously from $8.50) on shares of PSQ in a research report on Thursday. View Our Latest Stock Report on PSQH PSQ Stock Performance Shares of PSQH stock opened at $3.81 on Monday. The company has a quick ratio of 4.93, a current ratio of 1.50 and a debt-to-equity ratio of 0.46. PSQ has a 52 week low of $3.66 and a 52 week high of $35.57. The stock has a market capitalization of $107.77 million, a PE ratio of -0.16 and a beta of 0.45. The firm has a 50 day moving average of $4.50 and a two-hundred day moving average of $5.02. PSQ (NYSE:PSQH – Get Free Report) last issued its quarterly earnings results on Thursday, March 14th. The company reported ($0.40) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.07. PSQ had a negative net margin of 674.94% and a negative return on equity of 762.28%. The company had revenue of $2.75 million during the quarter, compared to analysts’ expectations of $2.47 million. Institutional Investors Weigh In On PSQ Institutional investors have recently modified their holdings of the company. PNC Financial Services Group Inc. acquired a new stake in PSQ during the 3rd quarter worth $27,000. Mariner LLC acquired a new stake in PSQ during the 3rd quarter worth $1,571,000. Capital Investment Counsel Inc acquired a new stake in PSQ during the 4th quarter worth $60,000. Axxcess Wealth Management LLC acquired a new stake in PSQ during the 3rd quarter worth $12,713,000. Finally, Calton & Associates Inc. acquired a new stake in PSQ during the 4th quarter worth $431,000. 17.32% of the stock is owned by hedge funds and other institutional investors. PSQ Company Profile (Get Free Report) PSQ Holdings, Inc, together with its subsidiaries, operates an online marketplace through advertising and eCommerce in the United States. It operates through two segments, Marketplace and Brands segments. The PSQ platform is accessible through its mobile application and website. The company also sells diapers and wipes to mothers online under the EveryLife brand name.
Q2 2024 EPS Estimates for PSQ Holdings, Inc. Reduced by Roth Capital (NYSE:PSQH)
PSQ Holdings, Inc. (NYSE:PSQH – Free Report) – Equities researchers at Roth Capital cut their Q2 2024 EPS estimates for shares of PSQ in a report released on Thursday, May 16th. Roth Capital analyst D. Aftahi now forecasts that the company will post earnings per share of ($0.30) for the quarter, down from their previous estimate of ($0.26). Roth Capital also issued estimates for PSQ’s Q3 2024 earnings at ($0.28) EPS, Q4 2024 earnings at ($0.24) EPS, Q1 2025 earnings at ($0.24) EPS, Q2 2025 earnings at ($0.22) EPS, Q3 2025 earnings at ($0.20) EPS, Q4 2025 earnings at ($0.17) EPS and FY2025 earnings at ($0.83) EPS. Separately, Roth Mkm reissued a “buy” rating and issued a $7.50 price target (down previously from $8.50) on shares of PSQ in a research report on Thursday. View Our Latest Stock Report on PSQH PSQ Stock Performance Shares of PSQH stock opened at $3.81 on Monday. The company has a quick ratio of 4.93, a current ratio of 1.50 and a debt-to-equity ratio of 0.46. PSQ has a 52 week low of $3.66 and a 52 week high of $35.57. The stock has a market capitalization of $107.77 million, a PE ratio of -0.16 and a beta of 0.45. The firm has a 50 day moving average of $4.50 and a two-hundred day moving average of $5.02. PSQ (NYSE:PSQH – Get Free Report) last issued its quarterly earnings results on Thursday, March 14th. The company reported ($0.40) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.07. PSQ had a negative net margin of 674.94% and a negative return on equity of 762.28%. The company had revenue of $2.75 million during the quarter, compared to analysts’ expectations of $2.47 million. Institutional Investors Weigh In On PSQ Institutional investors have recently modified their holdings of the company. PNC Financial Services Group Inc. acquired a new stake in PSQ during the 3rd quarter worth $27,000. Mariner LLC acquired a new stake in PSQ during the 3rd quarter worth $1,571,000. Capital Investment Counsel Inc acquired a new stake in PSQ during the 4th quarter worth $60,000. Axxcess Wealth Management LLC acquired a new stake in PSQ during the 3rd quarter worth $12,713,000. Finally, Calton & Associates Inc. acquired a new stake in PSQ during the 4th quarter worth $431,000. 17.32% of the stock is owned by hedge funds and other institutional investors. PSQ Company Profile (Get Free Report) PSQ Holdings, Inc, together with its subsidiaries, operates an online marketplace through advertising and eCommerce in the United States. It operates through two segments, Marketplace and Brands segments. The PSQ platform is accessible through its mobile application and website. The company also sells diapers and wipes to mothers online under the EveryLife brand name.
05/20 00:00 EST - https://www.zacks.com
Goldman (GS) Plans to Expand Private Equity Credit Lines
The Goldman Sachs Group, Inc. (GS Quick QuoteGS - Free Report) plans to ramp up its lending services to private equity and asset managers, per Reuters. The bank also intends to expand internationally, filling the gaps created by the problems at regional banks and the recent sale of Credit Suisse.The private equity market has a strong potential to grow as private equity deals are expected to rise, driven by record-high fundraising. These loans are classified as short-term, typically secured by the assets of the borrowing firms and hence have a lesser risk attached to them. Hence, GS’ focus on the private equity market is a strategic fit.Asset-secured lending will allow GS to expand its financing business in fixed income, currency and commodities (FICC) and equities space. The move is in line with the company’s key focus on enhancing the stability of revenue generation in its global banking and markets divisions.In the past to seven years, Goldman's deposit base experienced tremendous growth. The bank is actively seeking to align its asset growth with this expansion. In 2023, GS took over a loan portfolio worth $15 billion from the failed Signature bank. This portfolio included loans to private equity firms and venture capital funds, which is a crucial part of its client base. These loans help manage a smooth flow of working capital for the bank, also known as capital call facilities or subscription line loans. Once Goldman strengthened its operations in the United States, the bank plans to expand its lending into Europe, the U.K. and Asia. They have already added staff in its Dallas and Bangalore offices to handle these loans.Markedly, Goldman decided to refocus on its core strengths of IB and trading operations while scaling back its consumer banking footprint and hence undertook a major business restructuring initiative. In first-quarter 2024, the company completed the sale of GreenSky, its home-improvement lending platform, to a consortium of investors. In second-half 2023, it sold its Personal Financial Management unit to Creative Planning. These are in line with its decision to focus on and grow core businesses where it showcased encouraging results given its strong leadership position, wide scale of operations and exceptional talent.In the past six months, the company’s shares have rallied 39.6% compared with the industry’s growth of 35.8%.Image Source: Zacks Investment ResearchGS currently sports a Zacks Rank #1 (Strong Buy). Apart from GS, major banks like JPMorgan Chase & Co. (JPM Quick QuoteJPM - Free Report) and The PNC Financial Services Group, Inc. (PNC Quick QuotePNC - Free Report) are also increasing their participation in the market worth $800 billion to $1 trillion. Also, JPM stepped up its lending functions after it acquired First Republic Bank in 2023. Similarly, in October 2023, PNC acquired loan commitments from Signature Bank worth approximately $16 billion. These efforts to further grow its loan balances are expected to offer support to the banks’ financials in the long run. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>
Goldman (GS) Plans to Expand Private Equity Credit Lines
The Goldman Sachs Group, Inc. (GS Quick QuoteGS - Free Report) plans to ramp up its lending services to private equity and asset managers, per Reuters. The bank also intends to expand internationally, filling the gaps created by the problems at regional banks and the recent sale of Credit Suisse.The private equity market has a strong potential to grow as private equity deals are expected to rise, driven by record-high fundraising. These loans are classified as short-term, typically secured by the assets of the borrowing firms and hence have a lesser risk attached to them. Hence, GS’ focus on the private equity market is a strategic fit.Asset-secured lending will allow GS to expand its financing business in fixed income, currency and commodities (FICC) and equities space. The move is in line with the company’s key focus on enhancing the stability of revenue generation in its global banking and markets divisions.In the past to seven years, Goldman's deposit base experienced tremendous growth. The bank is actively seeking to align its asset growth with this expansion. In 2023, GS took over a loan portfolio worth $15 billion from the failed Signature bank. This portfolio included loans to private equity firms and venture capital funds, which is a crucial part of its client base. These loans help manage a smooth flow of working capital for the bank, also known as capital call facilities or subscription line loans. Once Goldman strengthened its operations in the United States, the bank plans to expand its lending into Europe, the U.K. and Asia. They have already added staff in its Dallas and Bangalore offices to handle these loans.Markedly, Goldman decided to refocus on its core strengths of IB and trading operations while scaling back its consumer banking footprint and hence undertook a major business restructuring initiative. In first-quarter 2024, the company completed the sale of GreenSky, its home-improvement lending platform, to a consortium of investors. In second-half 2023, it sold its Personal Financial Management unit to Creative Planning. These are in line with its decision to focus on and grow core businesses where it showcased encouraging results given its strong leadership position, wide scale of operations and exceptional talent.In the past six months, the company’s shares have rallied 39.6% compared with the industry’s growth of 35.8%.Image Source: Zacks Investment ResearchGS currently sports a Zacks Rank #1 (Strong Buy). Apart from GS, major banks like JPMorgan Chase & Co. (JPM Quick QuoteJPM - Free Report) and The PNC Financial Services Group, Inc. (PNC Quick QuotePNC - Free Report) are also increasing their participation in the market worth $800 billion to $1 trillion. Also, JPM stepped up its lending functions after it acquired First Republic Bank in 2023. Similarly, in October 2023, PNC acquired loan commitments from Signature Bank worth approximately $16 billion. These efforts to further grow its loan balances are expected to offer support to the banks’ financials in the long run. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>
05/16 12:31 EST - zacks.com
The PNC Financial Services Group (PNC) Up 9.6% Since Last Earnings Report: Can It Continue?
The PNC Financial Services Group (PNC) reported earnings 30 days ago. What's next for the stock?
The PNC Financial Services Group (PNC) Up 9.6% Since Last Earnings Report: Can It Continue?
The PNC Financial Services Group (PNC) reported earnings 30 days ago. What's next for the stock?
05/15 09:10 EST - prnewswire.com
PNC Executives To Speak At Bernstein Conference
PITTSBURGH , May 15, 2024 /PRNewswire/ -- The PNC Financial Services Group, Inc. (NYSE: PNC) announced today that Chairman and Chief Executive Officer William S. Demchak and Executive Vice President and Chief Financial Officer Robert Q.
PNC Executives To Speak At Bernstein Conference
PITTSBURGH , May 15, 2024 /PRNewswire/ -- The PNC Financial Services Group, Inc. (NYSE: PNC) announced today that Chairman and Chief Executive Officer William S. Demchak and Executive Vice President and Chief Financial Officer Robert Q.
05/09 13:36 EST - zacks.com
PNC Financial (PNC) Launches Credit Card With Cashback Feature
PNC Financial (PNC) unveils its new PNC Cash Unlimited Visa Signature credit card. It is set to offer the bank a competitive edge over its peers.
PNC Financial (PNC) Launches Credit Card With Cashback Feature
PNC Financial (PNC) unveils its new PNC Cash Unlimited Visa Signature credit card. It is set to offer the bank a competitive edge over its peers.
05/07 13:51 EST - zacks.com
PNC Financial (PNC), TCW Partner for Private Credit Platform
PNC Financial (PNC) partners with TCW to offer private credit solutions to middle-market companies. This will help it tap into the expanding private credit market.
PNC Financial (PNC), TCW Partner for Private Credit Platform
PNC Financial (PNC) partners with TCW to offer private credit solutions to middle-market companies. This will help it tap into the expanding private credit market.
05/07 10:00 EST - prnewswire.com
PNC Bank Introduces New Cash Unlimited Visa Signature® Credit Card Offering 2% Cash Back Across All Eligible Purchases
Embracing simplicity and competitive value, the new card delivers a suite of benefits that help meet today's consumer needs PITTSBURGH , May 7, 2024 /PRNewswire/ -- PNC Bank announced today the launch of its newest credit card, the PNC Cash Unlimited® Visa Signature credit card. The bank's latest credit card is designed to provide straightforward, valuable rewards to its cardholders with an unlimited 2% cash back on all eligible purchases.
PNC Bank Introduces New Cash Unlimited Visa Signature® Credit Card Offering 2% Cash Back Across All Eligible Purchases
Embracing simplicity and competitive value, the new card delivers a suite of benefits that help meet today's consumer needs PITTSBURGH , May 7, 2024 /PRNewswire/ -- PNC Bank announced today the launch of its newest credit card, the PNC Cash Unlimited® Visa Signature credit card. The bank's latest credit card is designed to provide straightforward, valuable rewards to its cardholders with an unlimited 2% cash back on all eligible purchases.
05/06 13:31 EST - youtube.com
TCW-PNC Platform Sets $2.5 Billion Private-Credit Goal
PNC Financial Services Group Inc.'s partnership with TCW Group Inc. to create a private-credit platform gives the bank a way to hold onto business that it might otherwise have had to send elsewhere, Bloomberg's John Sage tells Sonali Basak on "Bloomberg Markets." The platform seeks to have $2.5 billion in its first year.
TCW-PNC Platform Sets $2.5 Billion Private-Credit Goal
PNC Financial Services Group Inc.'s partnership with TCW Group Inc. to create a private-credit platform gives the bank a way to hold onto business that it might otherwise have had to send elsewhere, Bloomberg's John Sage tells Sonali Basak on "Bloomberg Markets." The platform seeks to have $2.5 billion in its first year.
05/06 13:03 EST - pymnts.com
PNC and TCW Partner on Loans to Middle Market Companies
The PNC Financial Services Group and the TCW Group have formalized and expanded their partnership to develop a private credit platform focused on middle market lending. The companies aim to have $2.
PNC and TCW Partner on Loans to Middle Market Companies
The PNC Financial Services Group and the TCW Group have formalized and expanded their partnership to develop a private credit platform focused on middle market lending. The companies aim to have $2.
05/06 10:18 EST - youtube.com
PNC, TCW Partner on Middle-Market Private Credit Platform
TCW Group is teaming up with PNC Financial Services Group on a private credit platform aimed at middle-market companies, targeting to have $2.5 billion in its first year. Sonali Basak reports on Bloomberg Television.
PNC, TCW Partner on Middle-Market Private Credit Platform
TCW Group is teaming up with PNC Financial Services Group on a private credit platform aimed at middle-market companies, targeting to have $2.5 billion in its first year. Sonali Basak reports on Bloomberg Television.
05/06 09:25 EST - prnewswire.com
PNC, TCW Partner To Expand Capabilities, Create Private Credit Platform
New Strategy Creates Opportunity for Significant Expansion in Middle Market Lending PITTSBURGH and LOS ANGELES , May 6, 2024 /PRNewswire/ -- The PNC Financial Services Group, Inc. ("PNC"), one of the largest diversified financial institutions in the U.S., and the TCW Group, Inc. ("TCW"), a leading global asset manager, today announced they are partnering to deliver private credit solutions to middle market companies. The PNC and TCW partnership formalizes and expands more than 15 years of collaboration between PNC and TCW, combining both institutions' credit expertise: TCW's 23-year track record of successfully originating, underwriting and managing direct lending portfolios; and the strengths of PNC's national client relationships and its leading middle market lending franchise.
PNC, TCW Partner To Expand Capabilities, Create Private Credit Platform
New Strategy Creates Opportunity for Significant Expansion in Middle Market Lending PITTSBURGH and LOS ANGELES , May 6, 2024 /PRNewswire/ -- The PNC Financial Services Group, Inc. ("PNC"), one of the largest diversified financial institutions in the U.S., and the TCW Group, Inc. ("TCW"), a leading global asset manager, today announced they are partnering to deliver private credit solutions to middle market companies. The PNC and TCW partnership formalizes and expands more than 15 years of collaboration between PNC and TCW, combining both institutions' credit expertise: TCW's 23-year track record of successfully originating, underwriting and managing direct lending portfolios; and the strengths of PNC's national client relationships and its leading middle market lending franchise.